In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nitromint Aerosol Drug Master File in Korea (Nitromint Aerosol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nitromint Aerosol. The MFDS reviews the Nitromint Aerosol KDMF as part of the drug registration process and uses the information provided in the Nitromint Aerosol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nitromint Aerosol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nitromint Aerosol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nitromint Aerosol suppliers with KDMF on PharmaCompass.